BioCentury
ARTICLE | Clinical News

AP1903 small molecule dimerizer regulatory update

February 28, 2000 8:00 AM UTC

The FDA granted Orphan Drug designation for AP1903 to treat acute graft-versus-host disease (GvHD) as part of the company's Argent dimerization gene expression system to induce apoptosis in transplanted T cells. ...